The number of med-spas, weight-loss clinics, and concierge practices where patients pay a membership fee for direct, often same-day access to physicians, has exploded in recent years. But while patients pay for these services out-of-pocket, providers still often rely on software built for traditional, insurance-based care.

VITL, an 18-month-old startup, claims to be solving one of the sector’s biggest tech bottlenecks by building an e-prescribing platform — a digital tool for sending and managing prescriptions — tailored for cash-pay medical businesses.

On Wednesday, VITL announced a $7.5 million Series A funding round led by SignalFire.

Founder and CEO Charlie Jordan built the Nashville-based company after realizing just how much time medical providers spend managing prescriptions for treatments not covered by insurance.

Many providers still rely on faxes or phone calls to send prescriptions to compounding pharmacies, which create custom medications to order, often without knowing the final cost to the patient or how long the order will take to fill. VITL’s platform fixes this by connecting clinics to a nationwide network of compounding pharmacies, offering real-time price comparisons and Amazon-style order tracking.

“We shorten the prescription time from several minutes down to a few seconds,” Jordan told TechCrunch.

For clinics that put in dozens of orders each day, that time savings adds up.

Techcrunch event

Disrupt 2026: The tech ecosystem, all in one room

Your next round. Your next hire. Your next breakout opportunity. Find it at TechCrunch Disrupt 2026, where 10,000+ founders, investors, and tech leaders gather for three days of 250+ tactical sessions, powerful introductions, and market-defining innovation. Register now to save up to $400.

Save up to $300 or 30% to TechCrunch Founder Summit

1,000+ founders and investors come together at TechCrunch Founder Summit 2026 for a full day focused on growth, execution, and real-world scaling. Learn from founders and investors who have shaped the industry. Connect with peers navigating similar growth stages. Walk away with tactics you can apply immediately

Offer ends March 13.

San Francisco, CA

October 13-15, 2026

VITL estimates that its technology saves clients up to two full workdays per month by automating an otherwise cumbersome and opaque process.

Cash-pay providers are clearly seeing the value in VITL’s platform. A little over a year after its launch, the company reports onboarding more than 630 clinics and generating eight figures in annualized recurring revenue (ARR), meaning the company is on pace to bring in at least $10 million per year.

That said, 630 customers represents just a fraction of a market that includes tens of thousands of clinics across the U.S. As interest in GLP-1s –the class of drugs that includes Ozempic and Wegovy — peptides, and aesthetic procedures like Botox grows more mainstream, the number of cash-pay healthcare businesses is only set to expand.

VITL never pitched SignalFire, but the startup’s rapid growth caught its attention. That interest translated into a new, $7.5 million Series A led by the venture firm, which is known for using data and AI to identify breakout companies.

VITL competes partly with Surescripts, the industry’s e-prescribing pioneer, and with boutique clinic platforms like Jane Software, which bundle prescription features into their broader electronic health record (EHR) software. What sets VITL apart from these competitors, it says, is its singular focus on the workflow requirements of the cash-pay medical sector.

Topics

Biotech & Health, medspa, prescriptions, signalfire, Startups, Venture

Marina Temkin

Reporter, Venture

Marina Temkin is a venture capital and startups reporter at TechCrunch. Prior to joining TechCrunch, she wrote about VC for PitchBook and Venture Capital Journal. Earlier in her career, Marina was a financial analyst and earned a CFA charterholder designation.

You can contact or verify outreach from Marina by emailing marina.temkin@techcrunch.com or via encrypted message at +1 347-683-3909 on Signal.

View Bio

June 9

Boston, MA

Actively scaling? Fundraising? Planning your next launch?

TechCrunch Founder Summit 2026 delivers tactical playbooks and direct access to 1,000+ founders and investors who are building, backing, and closing.

Riding the GLP-1 boom, VITL lands $7.5M to overhaul cash-pay clinic prescribing